These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Nefazodone relief of alprazolam interdose dysphoria: a potential therapeutic benefit of 3A3/4 inhibition. Ketter TA; Callahan AM; Post R J Clin Psychiatry; 1996 Jul; 57(7):307. PubMed ID: 8666573 [No Abstract] [Full Text] [Related]
25. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression. Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358 [TBL] [Abstract][Full Text] [Related]
29. Can the findings of antidepressant efficacy trials be extrapolated to the general population of depressed patients? Interview by Dr. Frederic Flach. Zimmerman M Essent Psychopharmacol; 2005; 6(2):118-25. PubMed ID: 15765796 [No Abstract] [Full Text] [Related]
30. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine. Owen JR; Nemeroff CB Depress Anxiety; 1998; 7 Suppl 1():24-32. PubMed ID: 9597349 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic dose range of nefazodone in the treatment of major depression. Robinson DS; Marcus RN; Archibald DG; Hardy SA J Clin Psychiatry; 1996; 57 Suppl 2():6-9. PubMed ID: 8626365 [TBL] [Abstract][Full Text] [Related]
33. Overview of psychiatric disorders and the role of newer antidepressants. Charney DS; Grothe DR; Smith SL; Brady KT; Kaltsounis-Puckett J; Wright CW; Laird LK; Rush AJ J Clin Psychiatry; 2002; 63 Suppl 1():3-9. PubMed ID: 11890562 [No Abstract] [Full Text] [Related]
34. Nefazodone may inhibit the metabolism of carbamazepine: three case reports. Roth L; Bertschy G Eur Psychiatry; 2001 Aug; 16(5):320-1. PubMed ID: 11514137 [No Abstract] [Full Text] [Related]
35. [Drug treatment of depression]. Opitz K Dtsch Med Wochenschr; 1987 Feb; 112(8):306-8. PubMed ID: 3816606 [No Abstract] [Full Text] [Related]
36. Depression in Parkinson's disease - a review. Wermuth L; Bech P Acta Neurol Scand; 2006 Nov; 114(5):360. PubMed ID: 17022788 [No Abstract] [Full Text] [Related]
38. [Critical comments on the methods of assessing the effectiveness of antidepressive pharmacotherapy]. Maier W; Benkert O Nervenarzt; 1987 Oct; 58(10):595-602. PubMed ID: 3317081 [No Abstract] [Full Text] [Related]
39. [Acute liver failure in nefazodone therapy? A case report]. Ehrentraut S; Rothenhäusler HB; Gerbes AL; Rau HG; Thiel M; Schirren CA; Kapfhammer HP Nervenarzt; 2002 Jul; 73(7):686-9. PubMed ID: 12212533 [TBL] [Abstract][Full Text] [Related]
40. Principles to optimize drug treatment in the depressed elderly: practical pharmacokinetics and drug interactions. Cohen LJ Geriatrics; 1995 Oct; 50 Suppl 1():S32-40. PubMed ID: 7493747 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]